Accenture (NYSE: ACN) and Duke University have formed an alliance focused on jointly developing new advanced analytics solutions to address real-world, client-specific business challenges. The Accenture and Duke University Analytics Research Program will have an initial focus on health management research.
“There are a number of Bayesian modelling packages available, but how do you know which one to use? This talk will take you through the positives and negatives of the major packages, focusing on the specifics of my work in health statistics, as well as providing a general overview of what these packages can do.”
Insilico Medicine to Utilize Deep Learning for Drug Repurposing and Discovery in Cancer and Age-Related Disease
Insilico Medicine, a bioinformatics company dedicated to drug discovery for cancer and aging, has launched its proprietary DeepPharma (TM) platform. DeepPharma utilizes the latest advances in deep learning to improve computer analysis of massive structured multi-omics data banks and millions of tissue-specific pathway activation profiles.
The partnership has seen Proskriptive integrate its predictive and prescriptive data models – designed to identify opportunities for quality improvement, operational efficiency, cost savings and enhanced patient care for payers, providers and those that provide products and services to the healthcare industry – with Yellowfin’s business-user-oriented BI platform.
Cognitive Scale announced an agreement with Deloitte Consulting LLP to deliver services and technology that will enable both companies to take a leadership position in transforming the delivery of healthcare to consumers and care providers through the application of cognitive cloud technology. Deloitte plans to leverage Cognitive Scale’s technology in a number of strategic initiatives.